Group II: Acute rejection treated with CsA 2mg/kg/d by subcutaneous injection from day 0-7. Group III: Acute rejection (LEW -to- BN).

• 排斥组从第3天逐步升高；高于同基因组和CsA处理组；与之相比差别有显著性(p刁.；047、0